These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 35625319)
1. The Class A β-Lactamase Produced by Becka SA; Zeiser ET; LiPuma JJ; Papp-Wallace KM Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625319 [TBL] [Abstract][Full Text] [Related]
2. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848 [TBL] [Abstract][Full Text] [Related]
3. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985 [No Abstract] [Full Text] [Related]
4. Activity of Imipenem-Relebactam against Multidrug- and Extensively Drug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli. Becka SA; Zeiser ET; LiPuma JJ; Papp-Wallace KM Antimicrob Agents Chemother; 2021 Oct; 65(11):e0133221. PubMed ID: 34370574 [TBL] [Abstract][Full Text] [Related]
10. Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Zeiser ET; Becka SA; Barnes MD; Taracila MA; LiPuma JJ; Papp-Wallace KM Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718248 [No Abstract] [Full Text] [Related]
11. Burkholderia ubonensis Meropenem Resistance: Insights into Distinct Properties of Class A β-Lactamases in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Bacteria. Somprasong N; Hall CM; Webb JR; Sahl JW; Wagner DM; Keim P; Currie BJ; Schweizer HP mBio; 2020 Apr; 11(2):. PubMed ID: 32291300 [No Abstract] [Full Text] [Related]
12. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients. Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560 [TBL] [Abstract][Full Text] [Related]
13. Tebipenem pivoxil hydrobromide-No PICC, no problem! Sodhi V; Kronsberg KA; Clark M; Cho JC Pharmacotherapy; 2021 Sep; 41(9):748-761. PubMed ID: 34370326 [TBL] [Abstract][Full Text] [Related]
14. Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen. Papp-Wallace KM; Becka SA; Taracila MA; Zeiser ET; Gatta JA; LiPuma JJ; Bonomo RA Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872073 [TBL] [Abstract][Full Text] [Related]
15. The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant Lomovskaya O; Rubio-Aparicio D; Tsivkovski R; Loutit J; Dudley M Antimicrob Agents Chemother; 2022 Feb; 66(2):e0216821. PubMed ID: 34902261 [TBL] [Abstract][Full Text] [Related]
16. Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans. Becka SA; Zeiser ET; Marshall SH; Gatta JA; Nguyen K; Singh I; Greco C; Sutton GG; Fouts DE; LiPuma JJ; Papp-Wallace KM Diagn Microbiol Infect Dis; 2018 Nov; 92(3):253-258. PubMed ID: 29983287 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Activity Evaluation of Tebipenem (SPR859), an Orally Available Carbapenem, against a Global Set of Enterobacteriaceae Isolates, Including a Challenge Set of Organisms. Arends SJR; Rhomberg PR; Cotroneo N; Rubio A; Flamm RK; Mendes RE Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936096 [TBL] [Abstract][Full Text] [Related]